Document is current
Any future updates will be listed below
-
Authors
,
Bührmann, Leah http://orcid.org/0000-0001-6957-4369
Schuurmans, Josien
Ruwaard, Jeroen
Fleuren, Margot
Etzelmüller, Anne
Piera-Jiménez, Jordi
Finch, Tracy
Rapley, Tim
Potthoff, Sebastian
Aouizerate, Bruno
Batterham, Philip J.
Calear, Alison
Christensen, Helen
Pedersen, Claus Duedal
Ebert, David Daniel
Van der Eycken, Erik
Fanaj, Naim
van Genugten, Claire
Hanssen, Denise
Hegerl, Ulrich
Hug, Juliane
Kleiboer, Annet
Mathiasen, Kim
May, Carl
Mustafa, Sevim
Oehler, Caroline
Cerga-Pashoja, Arlinda
Pope, Catherine
Qirjako, Gentiana
Rosmalen, Judith
Sacco, Ylenia
Samalin, Ludovic
Skjøth, Mette Maria
Tarp, Kristine
Titzler, Ingrid
Zanalda, Enrico
Zbukvic, Isabel
Smit, Johannes H.
Riper, Heleen
Vis, Christiaan
-
Funding
Funding for this research was provided by:
H2020 Health (733025)
National Health and Medical Research Council (1142363)
- License Information
-
More Information
Article History
Received: 3 February 2020
Accepted: 14 August 2020
First Online: 28 October 2020
Ethics approval and consent to participate
: Implementation sites have presented the study protocol for the implementation effectiveness study to local medical ethical committees and relating regulatory agencies. The committees concluded that this study is to be regarded as implementing evidence-based interventions and no human or animal experiments are involved. Approval letters from the committees are available on request. In Albania, there is no functional national ethical committee yet. As soon as this committee is established, the Albanian partner will submit their protocol for approval. In the meantime, they received approval from their institution to participate in the trial. Ethical approval for the process evaluation was granted by the University of Northumbria, UK (Submission Ref: 11039). Participants are required to provide and sign an informed consent indicating the purpose of the study, the nature, use and management of their data.
: Not applicable.
: Professor Bruno Aouizerate has received honoraria or consulting fees from Janssen-Cilag, Lundbeck, and Lilly. Dr. Samalin has received grants, honoraria, or consulting fees from Janssen-Cilag, Lundbeck, and Otsuka. All other authors declare that they have no competing interests.
